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Introduction
Embryonic stem (ES) cells have an indefinite proliferative life 
span and have a potential for both generating daughter cells 
with equivalent potential or cells ready for differentiation, that 
is, to establish unique gene expression profiles characteristic to 
different cell and tissue types during development. The delicate 
balance between self-renewal and the competency-to-differen-
tiate, is achieved by epigenetic and transcription control. This 
process is tightly regulated by transcription factors and chro-
matin-associated proteins, which respond to signalling path-
ways which in turn responds to environmental cues.1 
Epigenetic and transcription factors bind genomic regions 
proximal (promoters) and distal (enhancers) to the gene tran-
scription start site (TSS) to control gene regulation. 
Collaborative efforts such as the FANTOM2 and Roadmap 
Epigenomics3 projects have now successfully built enhancer 
and promoter repertoires across hundreds of cell types with an 
estimated 1.4% of the human genome associated to putative 
promoters and about 13% to putative enhancers. The vast 
majority of disease susceptibility loci lie in non-coding 
genomic regions, particularly in enhancer regions4,5 and have 
been estimated to explain a greater proportion of the heritabil-
ity for some disorders than variants in coding regions.6,7 
Despite their known functional importance during develop-
ment and disease, computational approaches towards 
genome-wide identification of enhancer elements remains a 
major challenge to date. This is due to various factors, includ-
ing enhancers are typically distal to the TSS with no fixed 
distance preference, can range from a few to few hundred 
bases length and tend to be cell-type specific.8 On the other 
hand, regulatory regions (enhancers and promoters) have 
sequence features enriched for motifs of known transcription 
factors and evolutionarily conserved facilitate computational 
prediction. Moreover, enhancers can be distinguished from 
promoters using the presence of certain regulatory proteins 
including p300 (an acetyltransferase), BRG1 (a chromatin 
remodelled), the presence of histone modifications (H3K4me1 
and H3K27ac), and unstable nucleosomes.9 Interestingly, sev-
eral experiments have recently shown that enhancer regions 
get transcribed to form short, often bidirectional transcripts, 
called enhancers RNAs or eRNAs.10 Enhancer RNA expres-
sion is correlated with the expression of target genes, many a 
times in a stimulus-dependent manner and therefore can be 
used to predict enhancers and their target genes.11 Several 
functional mechanisms of gene regulation have been described 
in literature including enhancer-promoter looping, recruiting 
transcriptional machinery, and facilitating RNA polymerase 
pause-release.12 It is important to note that, eRNAs might not 
always be a predictor of enhancer activity or localisation, and 
not all functional enhancers have to be transcribed in eRNAs.
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Enhancer regions have been classified into different groups 
based on their length, motif content, or chromatin status.13 
Super-enhancers were defined as large genomic regions (>3 kb) 
near highly expressed genes, differing from typical enhancers in 
size, transcription factor density and content, ability to activate 
transcription, and sensitivity to perturbation.14 But, a CRISPR/
Cas9-mediated deletion several super-enhancers clusters and 
isolated enhancers in mouse ES cells demonstrated enhancers 
and super-enhancers have an equivalent regulatory role in ES 
cells15 and iPS cells.16 The chromatin state is thought to be 
more functionally relevant with positive feedback loop between 
permissive chromatin and translation during early embryonic 
development.17 It is important to note that though histone 
modifications are widely used to define chromatin functional 
state, they are only predictions and not a proven fact. 
Furthermore, the experimental validations have demonstrated 
that they contain large number of false positives.16,18 Enhancers 
are marked by putative active (H3K4me1) or putative repressive 
(H3K27me3) chromatin modifications according to the cellular 
context. H3K4me3 (putative active) and H3K27me3 (putative 
repressive) modifications were found co-localised at promoters 
and enriched in developmentally regulated genes in mouse ES 
cells.19 Bivalent promoters were subsequently identified in 
human ES cells and were similarly enriched for developmental 
regulators20 and conserved their chromatin signature across spe-
cies.21 The bivalent state is thought to assure silencing of key 
developmental controllers in ES cells while keeping them 
poised for activation during differentiation.22 Similar to pro-
moters, putative enhancers marked with the bivalent enhancers 
are defined by the presence of the repressive mark H3K27me3 
and active mark H3K4me1. Bivalent promoters identified in 
many mature lineages including T-cells,23 neural progenitor 
cells (NPCs), and mouse embryonic fibroblast (MEFs).24 
Similarly, putative bivalent enhancers were identified in pro-B 
cells and adult liver,25 fibroblast-derived adipocytes, and bone-
marrow macrophages.26 In summary, bivalent domains are pre-
sent in enhancers and promoters and are thought to prime 
regulatory regions for their differentiation trajectory.27 An inte-
grative analysis of bivalent promoters in mouse ES cells demon-
strated that most H3K27me3 promoters were bivalent.28 
Importantly, most bivalent promoters did not resolve into active 
or repressed chromatin in differentiated lineages, with many 
bivalent chromatin domains in fact remained bivalent across 
diverse cell types.29
Similarly, to study the functional relevance of chromatin 
signature of enhancer elements, we performed systematic anal-
ysis of putative enhancers in mouse ES cells by data integra-
tion. Specifically, we first grouped putative enhancers into 5 
groups using multiple H3K4me1, H3K27ac, and H3K27me3 
modification data sets. Putative active enhancers (simultaneous 
presence of H3K4me1 and H3K27ac) were enriched for bind-
ing of pluripotency factors and were found near pluripotency-
related genes. Although both putative H3K4me1-only and 
active enhancers were enriched for super-enhancers and a 
TATA box like motif, putative active enhancers were preferen-
tially bound by RNA polII s2 form and were enriched for bidi-
rectional transcription, while putative H3K4me1-only 
enhancers were enriched for RNA polII (8WG16) suggesting 
they were likely poised. Putative bivalent enhancers (simulta-
neous presence of H3K4me1 and H3K27me3) were preferen-
tially in the vicinity of bivalent genes. They were enriched for 
binding of components of polycomb complex as well as Tcf3 
and Oct4. Moreover, a ‘CTTTCTC’ de-novo motif was 
enriched at putative bivalent enhancers, previously identified at 
bivalent promoters in ES cells.
Material and Methods
Data collection and processing
We collected ChIP sequencing raw data for H3K4me1, 
H3K27ac, and H3K27me3 profiles with 4 samples of each type 
in mouse ES cells from GEO30 and Roadmap Epigenomics.31 
The accession numbers (containing the information about the 
ES cell lines and culture conditions) for raw data for each sam-
ple are provided in Supplemental Table S1. After mapping the 
reads to mm10 genome assembly, we called peaks in each sam-
ple using SICER.32 Input controls were not used, if they were 
not available for the samples. Specific parameters for running 
SICER for H3K4me3 and H3K27ac window = 200 and gap 
size = 200 and for H3K27me3, window = 200 and gap 
size = 2 × 300, since H3K27me3 covers wider chromatin 
domains. The rest of the parameters (same for H3K4me3, 
H3K27ac, and H3K27me3) were effective genome fraction = 0.7, 
redundancy threshold = 1, fragment size = 150 and E-value = 100. 
We filtered out GENCODE M2 TSSs, which include both 
protein-coding and non-coding genes, to select enhancer peaks 
(Supplemental Table S1). Promoter regions were defined as 
1 kb region around GENCODE TSSs.
Putative enhancer classif ication
We created a genomic region by sample matrix by merging all 
peak files where ‘1’ represented a peak present in a given 
genomic region in a given sample and ‘0’ otherwise. Specifically, 
H3K4me1 peaks across diverse tissue and cell lines from 
ENCODE mouse data and 4 samples ES cell were merged 
using the following schema (Supplemental Table S2). The 
H3K4me1 peaks with an overlap of at least 25% with one of 
the peaks where the width of the merged peak was the union of 
2 peaks. The merged list of H3K4me1 peaks was treated as 
‘putative enhancers’ forming the rows of the matrix described 
above. The peaks for H3K4me1, H3K27ac, and H3K27me3 in 
ES cells overlapping at least 25% of the ‘putative enhancer’ 
peaks were considered overlapping and the H3K4me3 peak 
was defined as putative enhancer region. We then identified 
high confidence putative active enhancers by simultaneous 
presence of H3K4me1 and H3K27ac in 3 or more sample pairs 
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and absence of H3K27me3 in all 4 samples and high confi-
dence putative bivalent enhancers by simultaneous presence of 
H3K4me1 and H3K27me3 in 3 or more sample pairs and 
absence of H3K27ac in all 4 samples. We also defined 
H3K4me1-only, H3K27ac-only, and H3K27me3-only peaks 
by the presence of each chromatin modification in 3 or more 
samples and absence of other modifications. We have provided 
the genomic co-ordinates for all predicted enhancers in each 
enhancer group as Supplementary Material 2.
Transcription and epigenetic control
To identify transcription and epigenetic factors enriched at 
putative bivalent, active, and H3K4me1-only enhancers, we 
used data from over 150 ChIP-seq experiments for transcrip-
tion and epigenetic factors in mouse ES cells33 and the signifi-
cance of overlap was calculated using a hypergeometric test. 
Enriched regions or peaks from ChIP sequencing data for epi-
genetic and transcription factors in mouse ES cells were down-
loaded from CODEX database.33 If the putative enhancer 
region from this study overlapped more than 50% with TF 
binding peaks from CODEX database, the peak was associated 
with the putative enhancer, that is, transcription factor was 
assumed to occupy that putative enhancer region. We collected 
ChIP sequencing data for 3 RNAPII modifications: 
RNAPIIS5P, RNAPIIS7P and 8WG16, PRC2 components: 
Suz12, Jarid2, and PRC1 subunits: Cbx7 and Ring1b in mouse 
ES cells and the enrichment of these factors at putative biva-
lent enhancers was calculated using BEDtools34 and density 
plots were visualised using R. The TSS sites from FANTOM5 
were downloaded from http://fantom.gsc.riken.jp/5/data/.
Enrichment analysis
The promoter regions in mouse ES cells grouped according to 
chromatin marks as bivalent, active (H3K4me3-only), 
H3K27me3-only, and latent (absence of both marks) were 
obtained from Mantsoki et al.28 The data for ES cell putative 
enhancers in 2i culture35 and ES cell putative super-enhanc-
ers14 was obtained from respective publications. The sequence 
motif enrichment analysis, the genomic location grouping 
(intergenic, intron, exon, TTS 3’ or 5’) as well as distance to the 
nearest TSS was calculated using HOMER.36 The de-novo 
motif analysis was performed using HOMER with default 
parameters. Mammalian conservation tracks were downloaded 
from UCSC genome browser and conservation status was 
assigned if more that 75% of region overlapped with mamma-
lian conserved regions. We used a stringent threshold to select 
the enriched motifs (motif must be present in at least 10% of 
sequences and with a P value < 1e−10). Gene ontology func-
tional analyses for the putative bivalent, active, and H3K4me1-
only enhancers were done using DAVID.37 The TSSs predicted 
by the CAGE data as putative enhancers were obtained from 
the FANTOM consortium.2 The enrichments of overlaps were 
calculated using a hypergeometric test and P values were cor-
rected using Bonferroni correction. The analysis was performed 
using R and shell scripts. All analysis was performed in mm10 
genome assembly. The data sets provided by authors in mm9 
were converted to mm10 using the liftover tool.38
Putative enhancers in other tissues and during 
reprogramming
The peaks for the chromatin marks (H3K4me1, H3K27me3, 
and H3K27ac) across mouse cell lines and tissues were down-
loaded from the mouse ENCODE resource https://genome.
ucsc.edu/encode/downloadsMouse.html (please refer to 
Supplemental Table S3 for details). The peaks for the chroma-
tin marks (H3K4me1, H3K27me3, and H3K27ac) during 
reprogramming by 4 transcription factors Oct4, Sox2, Klf4, 
and Myc (OSKM) towards pluripotency were obtained from 
GEO, GSE67520.39
Results
Classif ication of putative enhancers in mouse ES 
cells by integrating ChIP-seq data
To identify and characterise putative enhancer elements in 
mouse ES cells, we collected ChIP sequencing data sets for 
H3K4me1, H3K27ac, and H3K27me3 modifications in mouse 
ES cells from independent studies (4 samples for each modifi-
cation, Supplemental Table S1). Putative enhancer peaks in 
each sample were determined by removing the peaks identified 
using SICER32 overlapping with GENCODE40 promoters. 
This resulted into about 120 thousand nonpromoter genomic 
regions with H3K4me1 modifications in at least 1 of 4 samples 
(Figure 1A). About half of these regions were occupied by 
H3K27ac in at least 1 of the 4 samples and about 20% of these 
regions were occupied by H3K27me3 in at least 1 of the 4 sam-
ples. Importantly, H3K27ac and H3K27me3 tended to be 
mutually exclusive. For example, of more than 9000 peaks with 
H3K4me1 and H3K27ac modifications in all 8 samples, more 
than 8000 had no H3K27me3 in any of the samples. 
Nevertheless, over 200 peaks were marked with both H3K27ac 
and H3K27me3 in at least 3 samples. We classified 21 725 
peaks with simultaneous presence of H3K4me1 and H3K27ac 
in 3 or more sample pairs and absence of H3K27me3 in all 4 
samples as high confidence putative active enhancers and 2935 
peaks with simultaneous presence of H3K4me1 and 
H3K27me3 in 3 or more sample pairs and absence of H3K27ac 
in all 4 samples as high confidence putative bivalent peaks. A 
total of 16 406 peaks present in 3 or more H3K4me1 samples 
and not in any of H3K27ac or H3K27me3 samples were called 
putative H3K4me-only enhancers. Similarly, 832 putative 
H3K27ac-only enhancers and 409 putative H3K27me3-only 
enhancers were defined (Figure 1B).
We mapped regulatory regions to the TSS of the nearest 
gene resulting into on average 2.5 regulatory regions mapped to 
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Figure 1. (A) The number of peaks in N (x axis) or more samples for each of the modification (H3K4me1 – red, H3K27ac – green, and H3K27me3–blue). 
(B) summary of enhancer groups based on the presence of histone modifications. (C) Gene ontology enrichment categories for the genes neighbouring 
bivalent, active and H3K4me1-only enhancers. (D) The fraction of transcription start sites in mouse ES cells identified by the FANTOM consortium 
overlapping with enhancer groups. (E) The fraction of enhancers in 2i- cultured ES cells and super-enhancers in ES cells overlapping with different 
enhancer groups. (F) The fraction of predicted by VISTA enhancer browser overlapping with different enhancer groups.
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a gene. We then calculated functional enrichment and pathway 
enrichments for each gene list (Figure 1C). Gene neighbouring 
‘putative active enhancers’ were enriched for pluripotency net-
work genes (P value < 8.6e−15) and genes neighbouring ‘puta-
tive bivalent enhancers’ were enriched for Wnt Signalling 
Pathway (P value < 7.5e−7) and TGF Beta Signalling Pathway 
(P value < 1.6e−5). Interestingly, genes neighbouring ‘putative 
H3K4me1-only enhancers’ were enriched for both pluripo-
tency network genes (P value < 8.8e−10) and Wnt Signalling 
Pathway (P value < 6.3e−7) and TGF Beta Signalling Pathway 
(P value < 1.8e−5).
Andersson et al41 used bidirectional expression from CAGE 
data to determine putative enhancer regions across multiple 
human and mouse cell types. We collected 44 507 bidirectional 
TSSs as well as 51 807 (positive-strand) and 46 434 (negative-
strand) unidirectional TSSs in ES cells from FANTOM5 
resource.2 We noted that significantly higher fraction of regu-
latory regions in all groups overlapped with bidirectional TSSs 
compared to unidirectional TSSs (Figure 1D). We noted that 
about a third of both putative active and bivalent enhancers 
showed bidirectional expression or in other words, the majority 
of the regulatory regions defined as active or bivalent using 
chromatin modifications were not identified using bidirec-
tional transcription signature.
Putative enhancers defined by published ChIP sequencing 
data of ES cells cultured in 2i medium condition35 showed a 
very small overlap with the enhancers in all 3 groups (Figure 
1E). In contrast, putative ‘super-enhancers’ in ES cells14 were 
highly enriched in both active and H3K4me1-only marked 
enhancers (Figure 1E). We collected enhancers predicted 
across diverse tissues and cell types in mouse from VISTA 
enhancer database42 and noted that they showed a small over-
lap with all putative enhancer groups (Figure 1F). Notably, 
putative H3K27me3-only enhancers showed similar overlap as 
putative active and bivalent enhancers (Figure 1F). We further 
confirmed that predicted enhancers across tissues in fact had a 
small overlap with all possible putative enhancers regions in ES 
cells (over 140 K), suggesting most tissue-specific enhancers 
are likely latent (with no histone modification) in ES cells.
Putative bivalent enhancers are enriched near 
bivalent gene promoters
We further analysed whether specific genomic regions were 
preferred by putative enhancers. Most putative enhancers were 
present in either intergenic or intronic regions for all putative 
enhancer types (Figure 2A). Given that mammalian genome 
has far more intergenic than intronic sequence, introns were 
enriched for enhancer elements of all types. Specifically, puta-
tive active and H3K4me1-only enhancers were highly enriched 
for intronic regions (P value < 1e−50) while putative bivalent 
enhancers were enriched to a lesser extent (P value < 1e−3).
We downloaded genomic regions conserved across mam-
mals from UCSC genome browser and noted that more than 
half of all putative enhancers were conserved across mammals. 
This fraction did not significantly change for any of the 
enhancer categories (Figure 2B).
To evaluate whether different putative enhancers showed a 
bias for specific genomic distance with respect to the nearest 
TSS. We calculated distance to the nearest TSS from each puta-
tive enhancer and noted that most enhancers were promoter 
distal with over half more than 50 kb away from the nearest TSS 
(Figure 2C). About 10% of H3K4me1-only enhancers formed 
an exception being within 5 kb of the nearest TSS.
We obtained the gene list likely to be regulated by putative 
enhancers in each category by mapping the putative enhancers 
to the TSS of the nearest gene (Supplemental Table S5). We 
have previously identified high-confidence bivalent, active 
(HK4me3 only), H3K4me3-only and latent (no mark) pro-
moters in mouse ES cells.28 To test whether specific enhancer 
types are enriched near specific promoter types, we calculated 
the gene overlap between enhancer and promoter categories. 
Putative bivalent enhancers were highly enriched near bivalent 
promoters (Figure 2D). This postulated that bivalent promot-
ers and enhancers might be part of a wider bivalent chromatin 
structure.
Specif ic epigenetic and transcription factors are 
enriched at putative active and bivalent enhancers
Voigt et al43 proposed that bivalency in ES cells was main-
tained due to occupancy of fewer transcription factors, while at 
active promoters, the H3K27me3 modification is averted by a 
high density of active transcription factors. We collected ChIP 
sequencing data for more than 150 factors in mouse ES cells33 
and noted that bivalent promoters were indeed occupied by 
fewer transcription factors compared to the H3K4me3-only or 
active promoters (Figure 3A, right). Interestingly though, we 
noted that more factors were bound at putative bivalent 
enhancers compared to putative active enhancers in mouse ES 
cells (Figure 3A, left). Both bivalent and active promoters were 
occupied by many more factors than putative bivalent and 
active enhancers.
Bivalent promoters belong to 2 distinct groups in mouse ES 
cells. The first class consists of domains where only PRC2 
exists ( ‘PRC2-only’) and the second one, called PRC1-
positive, where PRC2 domains are also occupied by PRC1. 
PRC1-positive, in contrast to PRC2-only, were more expan-
sive bivalent regions, highly conserved, and consisted numer-
ous developmental promoters.44 We collected ChIP sequencing 
data for epigenetic and RNAPII modifications known to dis-
tinguish bivalent promoter subtypes.28 Specifically, we grouped 
2 RNAPII modifications: RNAPIIS5P and RNAPIIS7P, 
8WG16 (an antibody recognising nonphosphorylated 
C-terminal domain), PRC2 components: Suz12, Jarid2, and 
PRC1 subunits: Cbx7 and Ring1b density at putative bivalent 
enhancers in mouse ES cells (Supplemental Figure S1). We 
noted that similar to promoters, a fraction of putative bivalent 
enhancers indeed showed a strong occupancy of polycomb and 
RNAPII. Never the less, these enhancers formed about 10% of 
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Figure 2. (A) The fraction each enhancer group in a specific genomic location (intergenic, intron, exon, 3’ and 5’) colour coded according to the enhancer 
group. (B) The fraction of each enhancer group overlapping with the mammalian conservation. (C) The fraction each enhancer group within a specific 
genomic distance window from the nearest TSS colour coded according to the distance window. (D) The overlap between the genes neighbouring the 
different promoter and enhancer groups representing bivalent enhancers and promoters are present near similar genes.
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putative bivalent enhancers (Supplemental Figure S1), unlike 
promoters which formed about half of bivalent promoters.
We further calculated enrichment for binding of individual 
factors at each putative enhancer group (Supplemental Table 
S6). Active enhancers were significantly enriched for p300 and 
core pluripotency factors including Oct4, Sox2, Nanog, 
Smad1, and Stat3. Importantly, these factors were not enriched 
at putative H3K4me1-only enhancers (Figure 3B). Putative 
H3K4me1-only enhancers were specifically enriched for 
Rbbp5 and Dpy30, the common regulatory components of 
MLL complex. Putative bivalent enhancers were enriched for 
polycomb components Suz12 and Ezh2. Interestingly, they 
were also enriched for 2 pluripotency factors Tcf3 and Oct4.
As the number of binding events vary greatly across factors 
affecting the enrichment, we calculated the fraction of peaks in 
each group occupied by a given factor. Ezh2, Kdm2b, Rnf2, and 
Klf2 were present at about a third of putative bivalent enhanc-
ers while Nanog, Pou5f1, Brd4, and Prdm14 were present at 
about a quarter of putative active enhancers (Figure 3C). P300, 
together with Utx and Mll4, facilitates conversion of inactive 
enhancers to active enhancers in ESCs.45 Interestingly, though 
p300 was enriched at putative active enhancers, it was present 
at the minority (less than 25%) of putative active enhancers. 
This can likely be due to the number of peaks called in p300 
ChIP-seq sample (9429 peaks) compared with more than 
21 000 predicted active enhancers.
Sequence motif enrichment at putative enhancer 
groups
In the previous section, we noted that putative active and biva-
lent enhancers were enriched for different epigenetic and tran-
scription controller. To investigate whether the binding 
enrichment of these factors is also reflected in sequence motif 
enrichments at putative active and bivalent enhancers, we cal-
culated known and de-novo motif enrichment using 
HOMER.36 We selected motifs enriched with a P value less 
that 1e−10 and present in at least 10% of enhancers. Both puta-
tive active and H3K4me1-only enhancers were enriched for 
KLF, FLI, and ETS motifs. Importantly, the sequence motif 
for pluripotency factors enriched at putative active enhancers 
was not highly enriched. This suggests that KLF, FLI, and 
ETS motifs might facilitate binding of pluripotency factors to 
the enhancers. Indeed, simultaneous depletion of Klf2, Klf4, 
and Klf5 lead to ES cell differentiation.46 No known motif was 
found enriched at bivalent enhancers using stringent cut-offs 
defined above. The lack of enrichment of known pluripotency 
factor motifs at putative active enhancers and polycomb com-
ples components at bivalent enhancers might be due to wider 
peaks called in histone modification data.
The de-novo motif search identified 3 motifs enriched in 
bivalent enhancers, 3 in putative active enhancers and 2 in 
putative H3K4me1-only enhancers (Figure 4B). The first 
de-novo motif identified at putative bivalent enhancers was 
previously identified enriched at bivalent promoters in ES 
cells.28 The second de-novo motif was similar to Myf6 from 
JASPAR database,47 while the third was present in about half 
of bivalent enhancers and was similar to Egr1 from JASPAR 
database.47 Of the 3 motifs in putative active enhancers, the 
first was similar to a POLII TATA box, the second similar to 
KLF motif while the third similar to MA0006.1, a bHLH 
motif from JASPAR database.47 Supporting known motif 
enrichments, the de-novo motif similar to TATA box was pre-
sent in active and H3K4me1-only enhancers. Putative 
H3K4me1-only specific de-novo motif was similar to Zbtb3 
motif from JASPAR database.47 As POLII TATA box like 
motif was enriched in putative active and H3K4me1-only 
enhancers, we calculated the overlap between enhancers and 3 
forms of RNA POLII binding (s2, s5, and 8GW16) using 
ChIP sequencing data.48 Putative H3K4me1-only enhancers 
showed a much higher overlap with 8WG16 antibody, recog-
nising nonphosphorylated Pol II while putative active enhanc-
ers showed a higher overlap for s2 antibody, specific for active, 
elongating Pol II (Supplemental Table S4).
ES putative enhancer status in mouse tissues and 
during cellular reprogramming
To study the dynamics of the 5 groups of putative enhancers in 
ES cells through differentiation, we collected H3K4me1, 
H3K27ac, H3K27me3 data for 10 tissues and cell types from 
the mouse ENCODE resource. Similar to the analysis of ES 
cells data, we classified the putative enhancers in each cell type 
in the same 5 groups, namely active, bivalent, H3K4me1-only, 
H3K27ac-only, and H3K27me3-only. We then calculated the 
overlap of each groups of putative enhancers in ES cells with all 
5 enhancers groups in each of the 10 tissue and cell types indi-
vidually (Figure 5, left). Putative active and H3K4me1-only 
enhancers in ES cells were mostly active or H3K4me1-only in 
other tissue of cell types (Figure 5A, C left). Putative bivalent 
enhancers in ES cells, though were predominantly H3K4me1-
only in other tissue and cell types, about 10% retained biva-
lency across other tissue and cell types (Figure 5B, left). 
Interestingly, about 20% of putative bivalent enhancers in ES 
cells were H3K27ac-only in heart and liver (Figure 5B, left).
To explore how the above-noted patterns might establish 
during differentiation, we collected time-series data during cel-
lular reprogramming by induced expression of 4 transcription 
factors Oct4, Sox2, Klf4, and Myc (OSKM) pushing somatic 
cell reprogramming towards pluripotency.39 Similar to the 
observation in other tissues and cell types, putative active and 
H3K4me1-only enhancers in ES cells were mostly active or 
H3K4me1-only during reprogramming. As expected putative 
active enhancers in ES cells showed a high overlap with puta-
tive active enhancers in iPSCs and putative H3K4me1-only 
enhancers also behaved similarly. Interestingly, putative 
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Figure 3. (A) The box plots of number of factors binding at different enhancer groups (left) and promoter groups (right) using CODEX database. (B) The 
epigenetic and transcription factors enriched at the active, bivalent, and H3K4me1-only enhancers. (C) The fraction of active, bivalent, and H3K4me1-only 
enhancers overlapping with peaks of different epigenetic and transcription factors. The factors at left are enriched in bivalent enhancers while the factors 
at right are enriched for the active enhancers.
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Figure 4. (A) Enriched known motifs at active and H3K4me1-only enhancers present in at least 10% of the enhancers identified by HOMER. (B) Enriched 
de-novo motifs at active and H3K4me1-only enhancers present in at least 10% of the enhancers identified by HOMER.
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Figure 5. (A) The fraction of active enhancers overlapping with enhancer groups across different tissues from the mouse ENCODE (left) and with 
enhancers groups during cellular reprogramming (right) (Cbellum = cerebellum and Wbrain = whole brain). (B) The fraction of bivalent enhancers 
overlapping with enhancer groups across different tissues from the mouse ENCODE (left) and with enhancers groups during cellular reprogramming 
(right). (C) The fraction of H3K4me1-only enhancers overlapping with enhancer groups across different tissues from the mouse ENCODE (left) and with 
enhancers groups during cellular reprogramming (right). (D) The fraction of H3K27ac-only enhancers overlapping with enhancer groups across different 
tissues from the mouse ENCODE (left) and with enhancers groups during cellular reprogramming (right).
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bivalent enhancers in ES cells lost H3K27me3 and gained 
H3K4me1 during reprogramming.
Discussion
Understanding enhancer function is fundamental to under-
standing cell-type-specific gene control. Here, we have defined 
putative enhancers based on the presence of H3K27ac, 
H3K27me3, and H3K4me1 modifications and characterised 
them in detail. We defined putative active enhancers by simul-
taneous presence of H3K4me1 and H3K27ac. We note that 
experimental validations of putative active enhancer predictions 
demonstrate that they contain high rate of false positives16,18 
and have led to other definitions of active enhancers but there 
is no agreed consensus. Simultaneous presence of H3K4me1 
and H3K27ac remains a common criterion used for identifica-
tion putative active enhancers. We note that in this study used 
only histone modification data, as the aim was to identify high 
confidence (relatively wide) regulatory regions and not identi-
fication of precise regulatory site within them. In latter case, 
one would ideally integrate other data including p300 binding 
or nucleosome depletion measured via ATAC-Seq or DNAse 
hypersensitivity assays. Furthermore, we mapped the regula-
tory regions to the nearest TSS. Although this is the most 
widely used approach to map putative targets of regulatory 
regions, it is important to note that the nearest neighbour gene 
is not always the enhancer target. There are many approaches 
to improve the mapping including chromatin capture assays to 
computational models.49
Putative active enhancers showed a high overlap with 
FANTOM bidirectional putative enhancers, ES putative 
super-enhancers, and binding of many pluripotency factors. 
We note that the FANTOM bidirectional putative enhancers 
were identified across diverse tissue and cell types and therefore 
limiting the overlap. The properties of active enhancers were 
distinct from putative H3K4me1-only enhancers corroborat-
ing that the presence of H3K27ac is sufficient to distinguish 
putative active enhancers.25 The higher overlap of putative 
H3K4me1-only enhancers with RNA POLII 8WG16 anti-
body, with no enrichment for bidirectional expression points 
out that they might be poised. Intriguingly, genes near 
H3K4me1-only enhancers were also enriched for pluripo-
tency-related genes. Furthermore, genes neighbouring ‘putative 
active enhancers’ were enriched for pluripotency network genes 
(P value < 8.6e−15) and genes neighbouring ‘putative bivalent 
enhancers’ were enriched for Wnt Signalling Pathway (P 
value < 7.5e−7), and TGF Beta Signalling Pathway (P 
value < 1.6e−5). Interestingly, genes neighbouring ‘putative 
H3K4me1-only enhancers’ were enriched for both pluripo-
tency network genes (P value < 8.8e−10) and Wnt Signalling 
Pathway (P value < 6.3e−7) and TGF Beta Signalling Pathway 
(P value < 1.8e−5). We noted that putative H3K4me1-only 
enhancers share the (nearest) genes with putative active and 
bivalent enhancers, resulting into enrichment for the signalling 
pathways. H3K4me1 modification has sharp ChIP-seq signal 
compared to both H3K27ac and H3K27me3 modifications 
and therefore more consistent peak detection across data sets. 
One of the possibilities therefore is that at least some of the 
putative H3K4me1-only enhancers were in-fact putative active 
(missing H3K27ac) or bivalent enhancers (missing 
H3K27me3). It is also worth noting that bivalent enhancers 
had all 3 RNA Pol II peaks present (Supplemental Table S4).
We defined putative bivalent enhancers by simultaneous 
presence of H3K4me1 and H3K27me3 modifications. Putative 
bivalent enhancers were present near bivalent promoters and 
many maintained bivalency through differentiation. Other 
definitions of putative bivalent enhancers include simultaneous 
presence of H3K27ac and DNA methylation.50 Bivalent 
regions selected by this definition show a high overlap with our 
‘putative active enhancers’ as most H3K27ac marked enhancers 
also carry H3K4me1 modification. Finally, we also identified a 
‘CTTTCTC’ de-novo motif enriched at bivalent enhancers 
previously identified at bivalent promoters.
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